Back to search
FDAFDA · Food and drugs·Recall number D-0516-2025

Lisdexamfetamine Dimesylate Capsules, 60 mg, CII, 100-count bottles, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceuticals, Inc., Cranbury, NJ 08512, NDC 57664-051-88

Published July 23, 2025 · Recall initiated: June 16, 2025

Summary

FDA records drug Class II recall D-0516-2025, published July 23, 2025 and initiated June 16, 2025. Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC; Status: Ongoing; Reported quantity: 5,448 bottles; Lot: Lot # AD42648, Exp 02/28/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 9 month long term stability station (25®C, 60%RH).

What to do

Voluntary: Firm initiated · Letter

Get an email if LISDEXAMFETAMINE DIMESYLATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
LISDEXAMFETAMINE DIMESYLATE
Manufacturer
SUN PHARMACEUTICAL INDUSTRIES INC
Distributor
Recalled units were distributed to 17 distributors who may have further distributed the product nationwide.
Lot
Lot # AD42648, Exp 02/28/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lisdexamfetamine Dimesylate Capsules, 60 mg, CII, 100-count bottles, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceuticals, Inc., Cranbury, NJ 08512, NDC 57664-051-88 recalled?

Yes. FDA published recall D-0516-2025 on July 23, 2025. Reported hazard: Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 9 month long term stability station (25®C, 60%RH).

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: LISDEXAMFETAMINE DIMESYLATE.